Serum resistin, cardiovascular disease and all-cause mortality in patients with type 2 diabetes.
<h4>Background</h4>High serum resistin has been associated with increased risk of cardiovascular disease in the general population, Only sparse and conflicting results, limited to Asian individuals, have been reported, so far, in type 2 diabetes. We studied the role of serum resistin on...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2014
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/adf5976560e04382b7b840439d03777b |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:adf5976560e04382b7b840439d03777b |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:adf5976560e04382b7b840439d03777b2021-11-18T07:43:17ZSerum resistin, cardiovascular disease and all-cause mortality in patients with type 2 diabetes.1932-620310.1371/journal.pone.0064729https://doaj.org/article/adf5976560e04382b7b840439d03777b2014-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23755138/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>High serum resistin has been associated with increased risk of cardiovascular disease in the general population, Only sparse and conflicting results, limited to Asian individuals, have been reported, so far, in type 2 diabetes. We studied the role of serum resistin on coronary artery disease, major cardiovascular events and all-cause mortality in type 2 diabetes.<h4>Methods</h4>We tested the association of circulating resistin concentrations with coronary artery disease, major cardiovascular events (cardiovascular death, non-fatal myocardial infarction and non-fatal stroke) and all-cause mortality in 2,313 diabetic patients of European ancestry from two cross-sectional and two prospective studies. In addition, the expression of resistin gene (RETN) was measured in blood cells of 68 diabetic patients and correlated with their serum resistin levels.<h4>Results</h4>In a model comprising age, sex, smoking habits, BMI, HbA1c, and insulin, antihypertensive and antidyslipidemic therapies, serum resistin was associated with coronary artery disease in both cross-sectional studies: OR (95%CI) per SD increment = 1.35 (1.10-1.64) and 1.99 (1.55-2.55). Additionally, serum resistin predicted incident major cardiovascular events (HR per SD increment = 1.31; 1.10-1.56) and all-cause mortality (HR per SD increment = 1.16; 1.06-1.26). Adjusting also for fibrinogen levels affected the association with coronary artery disease and incident cardiovascular events, but not that with all cause-mortality. Finally, serum resistin was positively correlated with RETN mRNA expression (rho = 0.343).<h4>Conclusions</h4>This is the first study showing that high serum resistin (a likely consequence, at least partly, of increased RETN expression) is a risk factor for cardiovascular disease and all-cause mortality in diabetic patients of European ancestry.Claudia MenzaghiSimonetta BacciLucia SalveminiChristine MendoncaGiuseppe PalladinoAndrea FontanaConcetta De BonisAntonella MarucciElizabeth GoheenSabrina PrudenteEleonora MoriniStefano RizzaAlyssa KanagakiGrazia FiniDavide MangiacottiMassimo FedericiSalvatore De CosmoFabio PellegriniAlessandro DoriaVincenzo TrischittaPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 6, p e64729 (2014) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Claudia Menzaghi Simonetta Bacci Lucia Salvemini Christine Mendonca Giuseppe Palladino Andrea Fontana Concetta De Bonis Antonella Marucci Elizabeth Goheen Sabrina Prudente Eleonora Morini Stefano Rizza Alyssa Kanagaki Grazia Fini Davide Mangiacotti Massimo Federici Salvatore De Cosmo Fabio Pellegrini Alessandro Doria Vincenzo Trischitta Serum resistin, cardiovascular disease and all-cause mortality in patients with type 2 diabetes. |
| description |
<h4>Background</h4>High serum resistin has been associated with increased risk of cardiovascular disease in the general population, Only sparse and conflicting results, limited to Asian individuals, have been reported, so far, in type 2 diabetes. We studied the role of serum resistin on coronary artery disease, major cardiovascular events and all-cause mortality in type 2 diabetes.<h4>Methods</h4>We tested the association of circulating resistin concentrations with coronary artery disease, major cardiovascular events (cardiovascular death, non-fatal myocardial infarction and non-fatal stroke) and all-cause mortality in 2,313 diabetic patients of European ancestry from two cross-sectional and two prospective studies. In addition, the expression of resistin gene (RETN) was measured in blood cells of 68 diabetic patients and correlated with their serum resistin levels.<h4>Results</h4>In a model comprising age, sex, smoking habits, BMI, HbA1c, and insulin, antihypertensive and antidyslipidemic therapies, serum resistin was associated with coronary artery disease in both cross-sectional studies: OR (95%CI) per SD increment = 1.35 (1.10-1.64) and 1.99 (1.55-2.55). Additionally, serum resistin predicted incident major cardiovascular events (HR per SD increment = 1.31; 1.10-1.56) and all-cause mortality (HR per SD increment = 1.16; 1.06-1.26). Adjusting also for fibrinogen levels affected the association with coronary artery disease and incident cardiovascular events, but not that with all cause-mortality. Finally, serum resistin was positively correlated with RETN mRNA expression (rho = 0.343).<h4>Conclusions</h4>This is the first study showing that high serum resistin (a likely consequence, at least partly, of increased RETN expression) is a risk factor for cardiovascular disease and all-cause mortality in diabetic patients of European ancestry. |
| format |
article |
| author |
Claudia Menzaghi Simonetta Bacci Lucia Salvemini Christine Mendonca Giuseppe Palladino Andrea Fontana Concetta De Bonis Antonella Marucci Elizabeth Goheen Sabrina Prudente Eleonora Morini Stefano Rizza Alyssa Kanagaki Grazia Fini Davide Mangiacotti Massimo Federici Salvatore De Cosmo Fabio Pellegrini Alessandro Doria Vincenzo Trischitta |
| author_facet |
Claudia Menzaghi Simonetta Bacci Lucia Salvemini Christine Mendonca Giuseppe Palladino Andrea Fontana Concetta De Bonis Antonella Marucci Elizabeth Goheen Sabrina Prudente Eleonora Morini Stefano Rizza Alyssa Kanagaki Grazia Fini Davide Mangiacotti Massimo Federici Salvatore De Cosmo Fabio Pellegrini Alessandro Doria Vincenzo Trischitta |
| author_sort |
Claudia Menzaghi |
| title |
Serum resistin, cardiovascular disease and all-cause mortality in patients with type 2 diabetes. |
| title_short |
Serum resistin, cardiovascular disease and all-cause mortality in patients with type 2 diabetes. |
| title_full |
Serum resistin, cardiovascular disease and all-cause mortality in patients with type 2 diabetes. |
| title_fullStr |
Serum resistin, cardiovascular disease and all-cause mortality in patients with type 2 diabetes. |
| title_full_unstemmed |
Serum resistin, cardiovascular disease and all-cause mortality in patients with type 2 diabetes. |
| title_sort |
serum resistin, cardiovascular disease and all-cause mortality in patients with type 2 diabetes. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2014 |
| url |
https://doaj.org/article/adf5976560e04382b7b840439d03777b |
| work_keys_str_mv |
AT claudiamenzaghi serumresistincardiovasculardiseaseandallcausemortalityinpatientswithtype2diabetes AT simonettabacci serumresistincardiovasculardiseaseandallcausemortalityinpatientswithtype2diabetes AT luciasalvemini serumresistincardiovasculardiseaseandallcausemortalityinpatientswithtype2diabetes AT christinemendonca serumresistincardiovasculardiseaseandallcausemortalityinpatientswithtype2diabetes AT giuseppepalladino serumresistincardiovasculardiseaseandallcausemortalityinpatientswithtype2diabetes AT andreafontana serumresistincardiovasculardiseaseandallcausemortalityinpatientswithtype2diabetes AT concettadebonis serumresistincardiovasculardiseaseandallcausemortalityinpatientswithtype2diabetes AT antonellamarucci serumresistincardiovasculardiseaseandallcausemortalityinpatientswithtype2diabetes AT elizabethgoheen serumresistincardiovasculardiseaseandallcausemortalityinpatientswithtype2diabetes AT sabrinaprudente serumresistincardiovasculardiseaseandallcausemortalityinpatientswithtype2diabetes AT eleonoramorini serumresistincardiovasculardiseaseandallcausemortalityinpatientswithtype2diabetes AT stefanorizza serumresistincardiovasculardiseaseandallcausemortalityinpatientswithtype2diabetes AT alyssakanagaki serumresistincardiovasculardiseaseandallcausemortalityinpatientswithtype2diabetes AT graziafini serumresistincardiovasculardiseaseandallcausemortalityinpatientswithtype2diabetes AT davidemangiacotti serumresistincardiovasculardiseaseandallcausemortalityinpatientswithtype2diabetes AT massimofederici serumresistincardiovasculardiseaseandallcausemortalityinpatientswithtype2diabetes AT salvatoredecosmo serumresistincardiovasculardiseaseandallcausemortalityinpatientswithtype2diabetes AT fabiopellegrini serumresistincardiovasculardiseaseandallcausemortalityinpatientswithtype2diabetes AT alessandrodoria serumresistincardiovasculardiseaseandallcausemortalityinpatientswithtype2diabetes AT vincenzotrischitta serumresistincardiovasculardiseaseandallcausemortalityinpatientswithtype2diabetes |
| _version_ |
1718423055567421440 |